Chen Thomas C 的 Form 4/A 修正申報
修正Neonc Technologies Holdings, Inc.（NTHI），2026/8/20 申報
- 申報編號
- 0001213900-26-092276
- 申報時間
- 2026/8/20 21:15 ET
- 交易日
- 2026/4/10-8/17
- 申報延遲
- 132 天
- 10b5-1 計畫
- 沒有勾選
- 原始申報日
- 2026/8/18
這份申報列了 4 筆非衍生性交易。公開市場買進合計 $19.3 萬。交易後 132 天申報。
這份修正申報取代了 0001213900-26-091231（2026/8/18 申報）。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Chen Thomas CCIK 0001998682 | 董事、高階主管（科學長）、持股 10% 以上大股東 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
The aggregate number of shares of Issuer's common stock (the "Shares") purchased by the Reporting Person on the same day at different prices.
- F2
Represents the weighted average purchase price. The Shares were purchased at prices ranging from $5.165 to $5.1722 per share, inclusive. Full information regarding the number of Shares sold at each price shall be provided to the Securities and Exchange Commission staff, Issuer or any security holder, upon request.
表 I 有 1 筆交易的價格引用這則附註。
- F3
Represents the weighted average purchase price. The Shares were purchased at prices ranging from $3.2299 to $4.0993 per share, inclusive. Full information regarding the number of Shares sold at each price shall be provided to the Securities and Exchange Commission staff, Issuer or any security holder, upon request.
表 I 有 1 筆交易的價格引用這則附註。
- F4
Includes shares of common stock held by certain members of Reporting Person's immediate family of which Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest, if any, therein.
- F5
Represents the weighted average purchase price. The Shares were purchased at prices ranging from $4.04 to $4.1699 per share, inclusive. Full information regarding the number of Shares sold at each price shall be provided to the Securities and Exchange Commission staff, Issuer or any security holder, upon request.
表 I 有 1 筆交易的價格引用這則附註。
- F6
Such shares represent only Reporting Person's percentage interest in HCWG LLC.
- F7
Shares held by NeuCen Biomedical Co. Ltd. ("NeuCen"). NeuCen is owned in part by Reporting Person's spouse. Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any, therein.
- F8
Shares held by T. R. Chen Third Family Limited Partnership, a NV limited partnership, of which Reporting Person and his spouse are the general partners with sole voting and dispositive power. Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any, therein.
- F9
Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest, if any, therein.